Study #2020-0124
Seizure control as a new metric in assessing efficacy of tumor treatment in patients with low grade glioma
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This study investigates how seizures can vary over time with changes in low grade gliomas and its treatments. This study may help doctors find symptoms or triggers of seizures earlier than normal, and ultimately earlier care or treatment for seizures.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Brain Neoplasm;Low Grade Glioma;Seizure Disorder
Study phase:
Physician name:
Ashley Aaroe
Department:
Neuro-Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.?